Search results
Author(s):
Mirvat Alasnag
,
Khalid Al Johani
,
Added:
9 months ago
In this episode of the Radcliffe Podcast, we are joined by Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA), Dr Khalid AlJohani (King Saud University, SA), and Dr Abdulrahman AlMoghairi (Prince Sultan Cardiac Center, SA) as they discuss methods and approaches to left main percutaneous coronary revascularization.
In this podcast, Dr Alasnag, Dr AlJohani and Dr AlMoghairi discuss the…
View more
Author(s):
Abdulrahman Almoghairi
,
Nayef Al-Asiri
,
Khalid Al Johani
,
et al
Added:
9 months ago
Left Main Percutaneous Coronary Revascularization
Author(s):
Mirvat Alasnag
,
Khalid Al Johani
,
Added:
9 months ago
Podcast Episode
PCI for Chronic Total Occlusion
Author(s):
Giovanni Maria Vescovo
,
Carlo Zivelonghi
,
Benjamin Scott
,
et al
Added:
3 years ago
Article
Author(s):
Binita Shah
Added:
4 years ago
Dr Binita Shah (NYU Langone Health, New York, NY, US) discusses Colchicine in Percutaneous Coronary Intervention (PCI).
Questions:
1.What is colchicine and why study it in PCI?
2.What was the study design, patient population and primary and secondary outcomes?
3.What were your outcomes?
4.How do these compare to those in the COLCOT study?
5.How should your study be interpreted in clinical…
View more
PCI in Women
Author(s):
Mirvat Alasnag
,
Valeria Paradies
,
Nicola Ryan
,
et al
Added:
4 months ago
Article
Author(s):
Jimmy Kerrigan
,
Timir K Paul
,
Jay Patel
,
et al
Added:
6 months ago
Author(s):
Ahmed M Alabbady
,
Ahmed S Abdul-Al
,
Kimberly A Skelding
Added:
3 years ago
The introduction of percutaneous coronary angioplasty in 1977 by Dr Andreas Grüntzig1 was one of the most remarkable achievements in the cardiology realm, opening the door to numerous advancements in percutaneous coronary interventions (PCIs). Due to advances in PCI techniques over the past four decades, catheters along with four generations of coronary stents have dramatically changed the…
View more
Author(s):
Rhian E Davies
,
J Dawn Abbott
Added:
3 years ago
Percutaneous Coronary Intervention for Clinical Syndromes
Stable Angina
The primary benefit of percutaneous coronary intervention (PCI) over medical therapy in patients with stable angina is the improved quality of life. The PCI in stable angina (ORBITA) trial was the first sham-controlled trial of PCI where 200 medically optimized patients with single vessel disease were randomized to PCI or…
View more